Health and Medicine

February 11, 2016

Study identifies potential colon cancer biomarker

A protein that suppresses a key cancer pathway in the colon may be a potential biomarker for colitis-associated tumors, researchers at Vanderbilt University Medical Center reported last month in the journal Gut.

By Bill Snyder
February 10, 2016

Overcoming lung cancer drug resistance

Vanderbilt investigators have discovered a way to overcome the resistance of some lung cancers to certain targeted therapies, which could lead to more effective treatments for lung cancer patients.

By Marilyn Holt
February 9, 2016

Therapies to prevent preterm birth

Vanderbilt researchers have developed a high-throughput assay that will aid in identifying new compounds to treat preterm labor or postpartum bleeding.

By Leigh MacMillan
February 8, 2016

Building intestinal brush borders

Studies of the molecular complex that helps build specialized cellular surfaces could shed light on the mechanisms underlying a genetic deaf-blindness syndrome accompanied by intestinal disease.

By Leigh MacMillan
bacteria microbiome
February 5, 2016

Dynamics of a drug resistance transporter

Vanderbilt investigators are exploring the shape changes in a multidrug transporter to understand the mechanisms of antibacterial resistance.

By VUMC News and Communications
older man
February 4, 2016

Prostate cancer survivors’ risk of heart disease studied

The 3 million prostate cancer survivors in the United States are likely to die from something other than cancer, thanks to early detection, effective treatment and the disease’s slow progression.

By Kathy Whitney
February 4, 2016

Grant spurs research into trauma-induced vision loss

Tonia Rex, Ph.D., and colleagues at the Vanderbilt Eye Institute are working to uncover how best to treat ocular trauma, the fourth leading cause of blindness worldwide.
By Jessica Pasley
February 1, 2016

VUMC study may offer answers for treating depression in alcoholics

A study by researchers at Vanderbilt University Medical Center is offering a glimmer of hope to alcoholics who find it hard to remain sober because their abstinence is hounded by stubborn, difficult-to-treat depression.
By Bill Snyder
January 28, 2016

Findings offer new insight on how cell division proteins work

A family of proteins with critical roles in cell division, synaptic transmission and cell migration don’t all function the way scientists thought they did, according to two new studies led by Vanderbilt researchers.
By Leigh MacMillan
January 28, 2016

Award recognizes Niswender’s research achievements

Kevin Niswender, M.D., Ph.D., a physician-scientist at Vanderbilt University Medical Center whose work has helped advance understanding of diseases ranging from obesity to schizophrenia, is one of 10 recipients of the 2016 Harrington Scholar-Innovator Awards.
By Bill Snyder
January 28, 2016

VUMC research shows patient privacy, ‘big data’ can coexist

A new study, led by investigators at Vanderbilt University Medical Center (VUMC), confirms that the scientific pursuit of so-called big data from hospitals and clinics needn’t conflict with patient privacy.
By Paul Govern
January 28, 2016

Autism study links sensory difficulties, serotonin system

Vanderbilt researchers have established a link between the neurotransmitter serotonin and certain behaviors of some children with autism spectrum disorder (ASD), a link that may lead to new treatments for ASD.
By VUMC News and Communications
January 27, 2016

Study identifies new culprit in lung cancer development

A microRNA — a small piece of RNA involved in regulating gene expression — functions as an oncogene to drive the development of lung cancer, Vanderbilt University investigators have discovered.
By Leigh MacMillan
1 … 103 104 105 106 107 … 192